Results 341 to 350 of about 3,334,579 (366)

Cytotoxic agents for use in dermatology. I

Journal of the American Academy of Dermatology, 1985
There are indications for the use of cytotoxic drugs in some dermatologic diseases. These drugs may be lifesaving for patients with diseases such as pemphigus, lymphomas, and vasculitis or they may merely offer an improved quality of life for patients who have diseases such as psoriasis, progressive systemic sclerosis, or sarcoidosis.
openaire   +3 more sources

Overview of biologic agents in medicine and dermatology

Seminars in Cutaneous Medicine and Surgery, 2005
Three agents have recently been approved by the Food and Drug Administration for the treatment of chronic plaque psoriasis: alefacept, efalizumab, and etanercept. The field of dermatology has now entered a new era, joining other disciplines of medicine that have been using biologic agents for decades.
openaire   +3 more sources

New Therapeutic Agents in Veterinary Dermatology

Veterinary Clinics of North America: Small Animal Practice, 1990
The rapid development of therapeutic agents will continue to provide veterinarians with new options in treating dermatologic disease. However, we must not overlook the possibility of new applications for older drugs. Ideally, before a drug can be recommended for routine use, it should be evaluated for safety and efficacy using unbiased scientific ...
openaire   +3 more sources

Management of antithrombotic agents in dermatologic surgery before and after publication of the corresponding German evidence‐based guideline

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2018
M. Gaskins, M. Dittmann, Lisa Eisert, R. Werner, C. Dressler, C. Löser, A. Nast   +6 more
semanticscholar   +1 more source

Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions: a systematic review with recommendations for prophylaxis

International Journal of Dermatology, 2016
Tania M. Gonzalez Santiago, D. Wetter, A. Kalaaji, A. Limper, J. Lehman   +4 more
semanticscholar   +1 more source

Chapter 20 Dermatological Agents

1987
Publisher Summary The field of dermatology encompasses biology, pharmacology, and pathophysiology, and is aimed at the development of more sophisticated and more effective therapies for diseases of the skin. This chapter discusses the previous review in this series, focusing on the newly developed treatments for acne, psoriasis, acute skin ...
openaire   +2 more sources

Dermatologic agents during pregnancy and lactation: an update and clinical review

International Journal of Dermatology, 2002
E. Hale, M. Pomeranz
semanticscholar   +1 more source

Topical antimicrobial agents in dermatology

Clinics in Dermatology, 2003
Susan C. Taylor, Candace Thornton Spann, Jeffrey M Weinberg   +2 more
openaire   +5 more sources

Dermatologic Reactions to Immune Checkpoint Inhibitors

American Journal of Clinical Dermatology, 2018
V. Sibaud
semanticscholar   +1 more source

Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions.

Journal of American Academy of Dermatology, 2010
J. Lehman, A. Kalaaji
semanticscholar   +1 more source